NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q1 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,269,441 | +0.1% | 22,280 | -0.9% | 1.80% | +6.0% |
| Q2 2023 | $2,267,650 | +6.5% | 22,472 | -2.9% | 1.69% | +0.4% |
| Q1 2023 | $2,129,800 | +1.5% | 23,150 | +0.1% | 1.69% | -3.4% |
| Q4 2022 | $2,097,900 | +11.5% | 23,125 | -0.3% | 1.75% | +8.0% |
| Q3 2022 | $1,882,000 | -99.9% | 23,195 | +1.2% | 1.62% | +6.2% |
| Q2 2022 | $1,937,850,000 | -4.9% | 22,925 | -1.3% | 1.52% | +22.6% |
| Q1 2022 | $2,037,291,000 | -0.6% | 23,217 | -1.0% | 1.24% | +3.3% |
| Q4 2021 | $2,050,296,000 | +11.6% | 23,440 | +4.3% | 1.20% | +0.3% |
| Q3 2021 | $1,837,596,000 | -6.6% | 22,470 | +4.2% | 1.20% | -3.4% |
| Q2 2021 | $1,968,046,000 | +6.4% | 21,570 | -0.3% | 1.24% | +3.1% |
| Q1 2021 | $1,849,787,000 | -7.8% | 21,640 | +1.9% | 1.20% | -18.2% |
| Q4 2020 | $2,005,693,000 | +10.3% | 21,240 | +1.6% | 1.47% | -4.6% |
| Q3 2020 | $1,817,898,000 | -0.0% | 20,905 | +0.4% | 1.54% | -10.2% |
| Q2 2020 | $1,818,418,000 | +5.7% | 20,820 | -0.2% | 1.72% | -9.5% |
| Q1 2020 | $1,720,731,000 | -14.7% | 20,870 | -2.1% | 1.90% | +22.9% |
| Q4 2019 | $2,018,317,000 | +3.4% | 21,315 | -5.1% | 1.54% | +2.5% |
| Q3 2019 | $1,951,340,000 | -2.6% | 22,455 | +2.3% | 1.51% | -11.4% |
| Q2 2019 | $2,003,341,000 | -4.0% | 21,940 | +1.1% | 1.70% | -9.1% |
| Q1 2019 | $2,086,718,000 | +10.5% | 21,705 | -1.4% | 1.87% | -2.0% |
| Q4 2018 | $1,888,249,000 | -1.0% | 22,005 | -0.6% | 1.91% | +18.3% |
| Q3 2018 | $1,908,013,000 | +12.4% | 22,145 | -1.4% | 1.61% | +6.5% |
| Q2 2018 | $1,697,383,000 | -20.0% | 22,470 | -14.4% | 1.52% | -9.3% |
| Q1 2018 | $2,122,313,000 | -1.4% | 26,250 | +2.4% | 1.67% | -2.1% |
| Q4 2017 | $2,151,475,000 | -1.7% | 25,625 | +0.5% | 1.71% | -6.5% |
| Q3 2017 | $2,188,745,000 | +2.8% | 25,495 | -0.1% | 1.82% | +0.7% |
| Q2 2017 | $2,129,319,000 | +11.8% | 25,510 | -0.6% | 1.81% | +8.4% |
| Q1 2017 | $1,905,396,000 | -1.0% | 25,655 | -2.9% | 1.67% | +2.0% |
| Q4 2016 | $1,924,068,000 | +1.9% | 26,415 | +15.4% | 1.64% | -9.8% |
| Q2 2016 | $1,888,653,000 | – | 22,890 | – | 1.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |